Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9160241rdf:typepubmed:Citationlld:pubmed
pubmed-article:9160241lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9160241lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:9160241lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:9160241lifeskim:mentionsumls-concept:C0085103lld:lifeskim
pubmed-article:9160241lifeskim:mentionsumls-concept:C0815000lld:lifeskim
pubmed-article:9160241lifeskim:mentionsumls-concept:C0006784lld:lifeskim
pubmed-article:9160241lifeskim:mentionsumls-concept:C0054534lld:lifeskim
pubmed-article:9160241lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:9160241lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:9160241pubmed:issue3lld:pubmed
pubmed-article:9160241pubmed:dateCreated1997-8-5lld:pubmed
pubmed-article:9160241pubmed:abstractTextCalpains have importance in human neurodegenerative disease pathogenesis, but these mechanisms are difficult to study in postmortem tissues. To establish a cellular model of the human calpain and calpastatin system, we characterized calpain I, calpain II, and calpastatin in SH-SY5Y human neuroblastoma cells in relation to their counterparts in human brain and investigated their expression and activity after inducing cellular differentiation with retinoic acid (RA), a physiological effector of normal brain development. Calpain I in both SH-SY5Y cells and human brain existed in the cytosolic and particulate fractions as three isoforms (80, 78, and 76 kDa) and exhibited atypical isoelectric focusing behavior. Calpain II in SH-SY5Y cells, as in human brain, migrated as a single predominantly cytosolic 76-kDa protein with an isoelectric point ranging from 5.9 to 6.3. Calpastatin from both sources was also 90% cytosolic. In the cells it was composed of four discrete bands, ranging in molecular weight from 110 to 127 kDa. Levels of activated (76 and 78 kDa) and precursor (80 kDa) calpain I isoforms rose 54% (P < 0.0001) in the particulate fraction and 26% (P < 0.0001) in the soluble fraction after 3 days of RA exposure. Because levels and activity of calpastatin remain unchanged during the first 7 days of RA exposure, the increased abundance of calpain I implies a net activation of the calpain system during differentiation. Calpain I activation may contribute to the remodeling of cell shape and neurite extension/retraction associated with neuronal differentiation.lld:pubmed
pubmed-article:9160241pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9160241pubmed:languageenglld:pubmed
pubmed-article:9160241pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9160241pubmed:citationSubsetIMlld:pubmed
pubmed-article:9160241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9160241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9160241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9160241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9160241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9160241pubmed:statusMEDLINElld:pubmed
pubmed-article:9160241pubmed:monthMaylld:pubmed
pubmed-article:9160241pubmed:issn0360-4012lld:pubmed
pubmed-article:9160241pubmed:authorpubmed-author:NixonR ARAlld:pubmed
pubmed-article:9160241pubmed:authorpubmed-author:MohanP SPSlld:pubmed
pubmed-article:9160241pubmed:authorpubmed-author:SheaT BTBlld:pubmed
pubmed-article:9160241pubmed:authorpubmed-author:GrynspanFFlld:pubmed
pubmed-article:9160241pubmed:authorpubmed-author:GriffinW BWBlld:pubmed
pubmed-article:9160241pubmed:issnTypePrintlld:pubmed
pubmed-article:9160241pubmed:day1lld:pubmed
pubmed-article:9160241pubmed:volume48lld:pubmed
pubmed-article:9160241pubmed:ownerNLMlld:pubmed
pubmed-article:9160241pubmed:authorsCompleteYlld:pubmed
pubmed-article:9160241pubmed:pagination181-91lld:pubmed
pubmed-article:9160241pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:meshHeadingpubmed-meshheading:9160241-...lld:pubmed
pubmed-article:9160241pubmed:year1997lld:pubmed
pubmed-article:9160241pubmed:articleTitleCalpains and calpastatin in SH-SY5Y neuroblastoma cells during retinoic acid-induced differentiation and neurite outgrowth: comparison with the human brain calpain system.lld:pubmed
pubmed-article:9160241pubmed:affiliationLaboratories of Molecular Neuroscience, Mailman Research Center, McLean Hospital, Belmont, MA 02178, USA.lld:pubmed
pubmed-article:9160241pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9160241pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9160241pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9160241pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9160241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9160241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9160241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9160241lld:pubmed